Avalo Therapeutics (AVTX) Short term Debt (2014 - 2019)
Avalo Therapeutics' (AVTX) quarterly Short term Debt came in at $1.2 million in Q3 2019, down 36.8% YoY from $2.0 million in Q3 2018, and down 19.09% on a QoQ basis from $1.5 million in Q2 2019.
Avalo Therapeutics (AVTX) Short term Debt (2014 - 2019) Analysis & Trends
Avalo Therapeutics (AVTX) has 6 years of Short term Debt data on file, last reported at $1.2 million in Q3 2019.
- Quarterly Short term Debt fell 36.8% year-over-year to $1.2 million in Q3 2019, while the trailing twelve-month figure through Sep 2019 was $1.2 million (down 36.8% YoY) and the FY2018 annual result came in at $859670.0, changed N/A from the prior year.
- Short term Debt retreated to $1.2 million in Q3 2019, from $1.5 million in the prior quarter.
- In the past five years, Short term Debt ranged from a high of $3.4 million in Q2 2016 to a low of $607598.0 in Q2 2017.
- A 5-year average of $2.0 million and a median of $2.0 million in 2018 frame the typical range for Short term Debt.
- Annual changes were most pronounced in 2017 — Short term Debt plunged 82.08% — and 2019, when it surged 165.98%.
- Tracing AVTX's Short term Debt over 5 years: stood at $3.2 million in 2015, then decreased by 26.63% to $2.4 million in 2016, then slumped by 74.19% to $607598.0 in 2017, then jumped by 41.49% to $859670.0 in 2018, then surged by 43.94% to $1.2 million in 2019.
- The last three Short term Debt figures came in at $1.2 million (Q3 2019), $1.5 million (Q2 2019), and $2.2 million (Q1 2019), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Avalo Therapeutics | 854.16 Mn | 453.89 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 1.24 Mn |
| Jun 30, 2019 | 1.53 Mn |
| Mar 31, 2019 | 2.21 Mn |
| Dec 31, 2018 | 859,670.00 |
| Sep 30, 2018 | 1.96 Mn |
| Jun 30, 2018 | 1.05 Mn |
| Mar 31, 2018 | 829,263.00 |
| Jun 30, 2017 | 607,598.00 |
| Mar 31, 2017 | 1.49 Mn |
| Dec 31, 2016 | 2.35 Mn |
| Sep 30, 2016 | 3.19 Mn |
| Jun 30, 2016 | 3.39 Mn |
| Mar 31, 2016 | 3.30 Mn |
| Dec 31, 2015 | 3.21 Mn |
| Sep 30, 2015 | 3.13 Mn |
| Dec 31, 2014 | 1.91 Mn |